“Saratoga’s solid performance is reflected in our continued strong key performance indicators this past quarter, including: (i) quarterly adjusted NII per share increases of 31% over the past year (77c to $1.01 per share), (ii) current assets under management growing to $1.114 billion, and (iii) dividends increasing to 72c per share, up 6% from 68c per share in Q3 last year and over earned by 40% as compared to this quarter’s $1.01 per share adjusted NII. The rapid increase in our adjusted earnings, more than 44% year-over-year, has resulted in substantial overearning of our dividend and a 15.4% earnings yield, building NAV and further supporting growth.”

“We have made substantial progress in building our NAV this year to further support the substantial growth of our portfolio, raising more than $48 million in new equity at net asset value, with $24 million raised in Q2, $10 million in Q3 and another $14 million since quarter-end. This equity supports our strong originations, strengthens our capital structure and reduces our regulatory leverage.”

“Most importantly, at the foundation of our performance is the high-quality nature, resilience and balance of our $1.114 billion portfolio in the current challenging environment, marked down 3% overall as compared to our cost and with our core non-CLO portfolio’s fair value less than 1% below its cost. While registering markdowns this quarter in a small number of specific credits and our overall CLO portfolio, the overall financial performance reflects the strength of our underwriting in our solid, growing portfolio companies and sponsors in well-selected industry segments.”

“We continue to remain prudent and discerning in terms of new commitments in the current volatile environment. Originations this quarter demonstrate that, despite an overall robust pipeline, there are periods when investments we review do not meet our high-quality credit and pricing standards, like this quarter where we originated zero new portfolio company investments and had fourteen smaller follow-on investments in existing portfolio companies we know well with strong business models and balance sheets. Originations this quarter totaled $35.6 million, with $2.1 million of repayments and amortization. Our credit quality for this quarter remained strong at 97.1% of credits rated in our highest category, with our investment in Zollege added as our third credit on non-accrual. With 86% of our investments at quarter-end in first lien debt and generally supported by strong enterprise values and balance sheets in industries that have historically performed well in stressed situations, we believe our portfolio and leverage is well structured for future economic conditions and uncertainty.”

“As we navigate through this challenging and volatile environment, we remain confident in our experienced management team, high underwriting standards and ability to steadily grow portfolio size and maintain quality and investment performance over the long-term.”

Discussion of Financial Results for the Quarter ended November 30, 2023:

As of November 30, 2023, Saratoga Investment’s AUM was $1.114 billion, an increase of 13.4% from $982.0 million as of November 30, 2022, and an increase of 1.4% from $1.099 billion as of August 31, 2023. The quarterly increase consists of $35.6 million in originations, offset by $2.1 million of repayments and amortizations, continuing the consistent long-term growth of the portfolio driven by our strong deal flow pipeline. In addition, during the second quarter the fair value of the portfolio was offset by $17.9 million of net unrealized depreciation, driven primarily by (i) the unrealized markdown of our Pepper Palace investment by a further $4.1 million due to company performance, (ii) the reversal of previously recognized unrealized appreciation and unrealized markdown of our Netreo Holdings investment by $8.3 million due to Company performance, (iii) the unrealized markdown of our ETU Holdings investment by $1.8 million due to Company performance, (iv) the unrealized markdown of our Zollege investment that has now been placed on non-accrual this quarter by $1.5 million due to Company performance, (v) the unrealized depreciation related to the CLO and JV of $6.5 million, reflecting primarily markdowns due to individual credits in the broadly syndicated portfolio and (vi) the impact of changes to market spreads, EBITDA multiples and/or revised portfolio company performance on the quarter-end valuations. The individual markdowns noted above was offset by $4.3 million unrealized appreciation across the remaining core BDC portfolio The net unrealized depreciation represented a 1.6% reduction in value of the overall portfolio.

Saratoga Investment’s portfolio remains strong, with 86.2% of the portfolio in first liens, and a continued high level of investment quality in loan investments, with 97.1% of its loans this quarter at its highest internal rating. Saratoga Investment’s portfolio has an overall fair value that is 2.9% below its cost basis, with the fair value of its core non-CLO portfolio 0.9% below its cost basis. Since Saratoga Investment took over the management of the BDC, $917.0 million of repayments and sales of investments originated by Saratoga Investment have generated a gross unlevered IRR of 15.7%.

For the three months ended November 30, 2023, total investment income of $36.3 million increased by $10.0 million, or 38.4%, from $26.3 million as compared to the three months ended November 30, 2022. As compared to the quarter ended August 31, 2023, total investment income grew by $0.8 million, or 2.3%, from $35.5 million. This quarter’s investment income was generated by (i) the impact of higher interest rates, both base rates and spreads, as compared to last year, with the weighted average current coupon on non-CLO BDC investments increasing from 11.7% to 12.5%, (ii) average non-CLO BDC assets increasing by 15.7% year-over-year, and by 1.6% since last quarter, and (iii) other income including a $1.3 million dividend received from the Saratoga Investment JV.

For the three months ended November 30, 2023, adjusted net investment income of $13.1 million increased by $4.0 million, or 43.8%, from $9.1 million for the quarter ended November 30, 2022, and decreased by $0.1 million, or 0.2%, from $13.2 million for the quarter ended August 31, 2023. The increases in investment income were offset by (i) increased interest expense resulting from the impact of various new Notes Payable and SBA debentures issued during the past year and quarter and (ii) increased base and incentive management fees from higher AUM and earnings.

Total expenses for the third fiscal quarter 2024, excluding interest and debt financing expenses, base management fees and incentive fees and income and excise taxes, increased from $2.1 million to $2.3 million as compared to the second fiscal quarter 2024, and increased from $2.1 million from the quarter ended November 30, 2022. This represented 0.8% of average total assets on an annualized basis, unchanged from 0.8% at both Q3 last year and last quarter.

Net investment income on a weighted average per share basis was $1.09 for the quarter ended November 30, 2023. Adjusted for the incentive fee accrual related to net capital gains, the net investment income on a weighted average per share basis was $1.01. This compares to adjusted net investment income per share of $0.77 and $1.08 for the quarters ended November 30, 2022, and August 31, 2023, respectively. The weighted average common shares outstanding of 13.1 million this quarter increased from 11.9 million and 12.2 million for the quarters ended November 30, 2022 and August 31, 2023, respectively. This resulted in an $0.08 dilutive impact to adjusted NII per share this quarter.

Net investment income yield as a percentage of average net asset value (“Net Investment Income Yield”) was 15.7% for the quarter ended November 30, 2023. Adjusted for the incentive fee accrual related to net capital gains, the Net Investment Income Yield was 14.6%. In comparison, adjusted Net Investment Income Yield was 10.8% and 15.0% for the quarters ended November 30, 2022 and August 31, 2023, respectively.

Return on equity for the last twelve months ended November 30, 2023 was 6.6%, down from 9.6% last quarter and up from 4.0% for the comparable period last year.

NAV was $359.6 million as of November 30, 2023, an increase of $23.8 million from $335.8 million as of November 30, 2022, and a decrease of $2.5 million from $362.1 million as of August 31, 2023. This includes $10.0 million of equity raised at NAV during the fiscal third quarter.

NAV per share was $27.42 as of November 30, 2023, compared to $28.25 as of November 30, 2022, and $28.44 as of August 31, 2023.

Investment portfolio activity for the quarter ended November 30, 2023:

• Cost of investments made during the period: $35.6 million, including zero investments in new portfolio companies and fourteen follow-ons.

• Principal repayments during the period: $2.1 million, including one partial repayment of an existing investment, plus amortization.

Additional Financial Information

For the fiscal quarter ended November 30, 2023, Saratoga Investment reported NII of $14.2 million, or $1.09 on a weighted average per share basis, and net realized and unrealized losses on investments of $18.2 million, or $1.40 on a weighted average per share basis, resulting in a net decrease in net assets from operations of $4.1 million, or $0.31 on a weighted average per share basis. The $18.2 million net realized and unrealized loss on investments was comprised of $17.8 million in net realized gains and unrealized depreciation on investments, and $0.4 million in net change in provision for deferred taxes on unrealized appreciation on investments.

This quarter’s $0.1 million realized gains related to an escrow payment received on the Company’s previously owned Ohio Medical investment.

Portfolio and Investment Activity

As of November 30, 2023, the fair value of Saratoga Investment’s portfolio was $1.114 billion, excluding $47.0 million in cash and cash equivalents, principally invested in 55 portfolio companies, one collateralized loan obligation fund (the “CLO”) and one joint venture fund (the “JV”). The overall portfolio composition consisted of 86.2% of first lien term loans, 1.3% of second lien term loans, 1.6% of unsecured term loans, 2.6% of subordinated notes in CLOs and 8.3% of common equity.

For the fiscal quarter ended November 30, 2023, Saratoga Investment invested $35.6 million in fourteen follow-ons in existing portfolio companies and had $2.1 million in aggregate amount of one partial exit and repayment, including realized gains, resulting in net originations of $33.5 million for the quarter.

As of November 30, 2023, the weighted average current yield on Saratoga Investment’s portfolio based on current fair values was 11.4%, which was comprised of a weighted average current yield of 12.6% on first lien term loans, 6.0% on second lien term loans, 10.0% on unsecured term loans, 10.7% on CLO subordinated notes and 0.0% on equity interests.

Liquidity and Capital Resources

As of November 30, 2023, Saratoga Investment had $35.0 million in outstanding borrowings under its $65.0 million senior secured revolving credit facility with Encina. At the same time, Saratoga Investment had $0.0 million SBA debentures in its SBIC I license outstanding, $175.0 million SBA debentures in its SBIC II license outstanding, $30.0 million SBA debentures in its SBIC III license outstanding, $269.4 million of listed baby bonds issued, $250.0 million of unsecured unlisted institutional bond issuances, five unlisted issuances of $52.0 million in total, and an aggregate of $47.0 million in cash and cash equivalents.

With $30.0 million available under the credit facility and $47.0 million of cash and cash equivalents as of November 30, 2023, Saratoga Investment has a total of $77.0 million of undrawn borrowing capacity and cash and cash equivalents for new investments or to support its existing portfolio companies in the BDC. In addition, Saratoga Investment has $145.0 million in undrawn SBA debentures from its recently approved SBIC III license. Availability under the Encina credit facility can change depending on portfolio company performance and valuation. In addition, certain follow-on investments in SBIC II and the BDC will not qualify for SBIC III funding. Overall outstanding SBIC debentures is limited to $350.0 million across all three SBIC licenses. As of quarter-end, Saratoga Investment had $50.7 million of committed undrawn lending commitments and $77.7 million of discretionary funding commitments.

On July 30, 2021, Saratoga Investment entered into an equity distribution agreement with Ladenburg Thalmann & Co. Inc. and Compass Point Research and Trading, LLC, through which Saratoga Investment may offer for sale, from time to time, up to $150.0 million of common stock through an ATM offering. On July 10, 2023, Saratoga Investment increased the maximum amount of shares of common stock to be sold through the ATM Program to $300.0 million from $150.0 million. As of November 30, 2023, Saratoga Investment sold 6,042,773 shares for gross proceeds of $158.3 million at an average price of $26.20 for aggregate net proceeds of $156.8 million (net of transaction costs). During the three months ended November 30, 2023, Saratoga Investment sold 350,000 shares for gross proceeds of $10.0 million at an average price of $28.48 for aggregate net proceeds of $10.0 million (net of transaction costs). During the nine months ended November 30, 2023, Saratoga Investment sold 1,202,412 shares for gross proceeds of $34.3 million at an average price of $28.54 for aggregate net proceeds of $34.3 million (net of transaction costs).

Dividend

On November 15, 2023, Saratoga Investment announced that its Board of Directors declared a quarterly dividend of $0.72 per share for the fiscal quarter ended November 30, 2023, paid on December 28, 2023, to all stockholders of record at the close of business on December 11, 2023. This is Saratoga Investment’s fifteenth quarterly dividend increase in a row.

The Company previously declared in fiscal 2024 a quarterly dividend of $0.71 per share for the quarter ended August 31, 2023 and $0.70 per share for the quarter ended May 31, 2023. During fiscal year 2023, the Company declared a quarterly dividend of $0.69 per share for the quarter ended February 28, 2023, $0.68 per share for the quarter ended November 30, 2022, $0.54 per share for the quarter ended August 31, 2022 and $0.53 per share for the quarter ended May 31, 2022. During fiscal year 2022, the Company declared a quarterly dividend of $0.53 per share for the quarters ended February 28, 2022 and November 30, 2021, $0.52 per share for the quarter ended August 31, 2021, $0.44 per share for the quarter ended May 31, 2021 and $0.43 per share for the quarter ended February 28, 2021.

Shareholders have the option to receive payment of dividends in cash or receive shares of common stock, pursuant to the Company’s DRIP.

Share Repurchase Plan

In fiscal year 2015, the Company announced the approval of an open market share repurchase plan that allows it to repurchase up to 200,000 shares of its common stock at prices below its NAV as reported in its then most recently published financial statements. Since then, the Share Repurchase Plan has been extended annually, and the Company has periodically increased the amount of shares of common stock that may be purchased under the Share Repurchase Plan, most recently to 1.7 million shares of common stock. On January 8, 2024, our board of directors extended the Share Repurchase Plan for another year to January 15, 2025.

As of November 30, 2023, the Company had purchased 1,035,203 shares of common stock, at the average price of $22.05 for approximately $22.8 million pursuant to the Share Repurchase Plan. During the three months ended November 30, 2023, the Company did not purchase any shares of common stock pursuant to the Share Repurchase Plan. During the nine months ended November 30, 2023 the Company purchased 88,576 shares of common stock, at the average price $24.36 for approximately $2.2 million pursuant to the Share Repurchase Plan.

2024 Fiscal Third Quarter Conference Call/Webcast Information

About Saratoga Investment Corp.

Saratoga Investment is a specialty finance company that provides customized financing solutions to U.S. middle-market businesses. The Company invests primarily in senior and unitranche leveraged loans and mezzanine debt, and, to a lesser extent, equity to provide financing for change of ownership transactions, strategic acquisitions, recapitalizations and growth initiatives in partnership with business owners, management teams and financial sponsors. Saratoga Investment’s objective is to create attractive risk-adjusted returns by generating current income and long-term capital appreciation from its debt and equity investments. Saratoga Investment has elected to be regulated as a business development company under the Investment Company Act of 1940 and is externally managed by Saratoga Investment Advisors, LLC, an SEC-registered investment advisor focusing on credit-driven strategies. Saratoga Investment Corp. owns two active SBIC-licensed subsidiaries, having surrendered its first license after repaying all debentures for that fund following the end of its investment period and subsequent wind-down. Furthermore, it manages a $650 million collateralized loan obligation (“CLO”) fund and co-manages a joint venture (“JV”) fund that owns a $400 million collateralized loan obligation (“JV CLO”) fund.  It also owns 52% of the Class F and 100% of the subordinated notes of the CLO, 87.5% of both the unsecured loans and membership interests of the JV and 87.5% of the Class E notes of the JV CLO. The Company’s diverse funding sources, combined with a permanent capital base, enable Saratoga Investment to provide a broad range of financing solutions.

Forward Looking Statements

This press release contains historical information and forward-looking statements with respect to the business and investments of the Company, including, but not limited to, the statements about future events or our future performance or financial condition. Forward-looking statements can be identified by the use of forward looking words such as “outlook,” “believes,” “expects,” “potential,” “continues,” “may,” “will,” “should,” “seeks,” “approximately,” “predicts,” “intends,” “plans,” “estimates,” “anticipates” or negative versions of those words, other comparable words or other statements that do not relate to historical or factual matters. The forward-looking statements are based on our beliefs, assumptions and expectations of our future performance, taking into account all information currently available to us. These statements are not guarantees of future performance, condition or results and involve a number of risks and uncertainties. Actual results may differ materially from those in the forward-looking statements as a result of a number of factors, including, but not limited to: changes in the markets in which we invest; changes in the financial, capital, and lending markets; an economic downturn and its impact on the ability of our portfolio companies to operate and the investment opportunities available to us; the impact of interest rate volatility on our business and our portfolio companies; the impact of supply chain constraints and labor shortages on our portfolio companies; and the elevated levels of inflation and its impact on our portfolio companies and the industries in which we invests, as well as those described from time to time in our filings with the Securities and Exchange Commission.

Any forward-looking statement speaks only as of the date on which it is made. The Company undertakes no duty to update any forward-looking statements made herein or on the webcast/conference call, whether as a result of new information, future developments or otherwise, except as required by law. Readers should not place undue reliance on any forward-looking statements and are encouraged to review the Company’s Annual Report on Form 10-K for the fiscal year ended February 28, 2023 and subsequent filings, including the “Risk Factors” sections therein, with the Securities and Exchange Commission for a more complete discussion of the risks and other factors that could affect any forward-looking statements.

Financials

Supplemental Information Regarding Adjusted Net Investment Income, Adjusted Net Investment Income Yield and Adjusted Net Investment Income per Share

On a supplemental basis, Saratoga Investment provides information relating to adjusted net investment income, adjusted net investment income yield and adjusted net investment income per share, which are non-GAAP measures. These measures are provided in addition to, but not as a substitute for, net investment income, net investment income yield and net investment income per share. Adjusted net investment income represents net investment income excluding any capital gains incentive fee expense or reversal attributable to realized and unrealized gains. The management agreement with the Company’s advisor provides that a capital gains incentive fee is determined and paid annually with respect to cumulative realized capital gains (but not unrealized capital gains) to the extent such realized capital gains exceed realized and unrealized losses for such year. In addition, Saratoga Investment accrues, but does not pay, a capital gains incentive fee in connection with any unrealized capital appreciation, as appropriate. All capital gains incentive fees are presented within net investment income within the Consolidated Statements of Operations, but the associated realized and unrealized gains and losses that these incentive fees relate to, are excluded. As such, Saratoga Investment believes that adjusted net investment income, adjusted net investment income yield and adjusted net investment income per share is a useful indicator of operations exclusive of any capital gains incentive fee expense or reversal attributable to gains. In addition, adjusted net investment income in fiscal 2023 also excludes the interest expense and amortization of deferred financing costs related to the 2025 SAK Notes during the period while the 2027 SAT Notes were already issued and outstanding. These expenses are directly attributable to the issuance of the 2027 SAT Notes and the subsequent repayment of the 2025 SAK Notes. The presentation of this additional information is not meant to be considered in isolation or as a substitute for financial results prepared in accordance with GAAP. The following table provides a reconciliation of net investment income to adjusted net investment income, net investment income yield to adjusted net investment income yield and net investment income per share to adjusted net investment income per share for the three and nine months ended November 30, 2023 and November 30, 2022.

Contact: Henri Steenkamp
Saratoga Investment Corp.
212-906-7800                                                                                                     

Roland Tomforde
Broadgate Consultants
212-232-2222